hVIVO plc Result of AGM (2274O)
26 Mai 2015 - 1:00PM
UK Regulatory
TIDMHVO
RNS Number : 2274O
hVIVO plc
26 May 2015
For immediate release 12.00pm: 26 May 2015
HVIVO PLC
("hVIVO" or the "Company")
Result of Annual General Meeting
hVIVO plc (AIM: RVG), the pioneer of human challenge models of
disease, is pleased to announce that all resolutions proposed at
its Annual General Meeting, held at 10am on 21 May 2015, were duly
passed.
For further information please contact:
hVIVO plc +44 207 756 1300
Kym Denny (Chief Executive Officer)
Graham Yeatman (Chief Financial & Business Officer)
Media Enquiries +44 203 021 3933 / +44 7854 979 420
Colin Paterson (Director of Marketing, Communication and Public
Relations)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
hVIVO plc ("hVIVO") is a life sciences company pioneering a
technology platform of human disease models to accelerate drug
development and discovery in respiratory and infectious diseases.
Based in the UK, hVIVO has conducted over 40 clinical studies,
involving more than 1950 volunteers for a range of leading
industry, governmental and academic clients.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGPKADPKBKDOPB
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Hvivo (LSE:HVO)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024